The Society of Hematologic Oncology
SOHO is a 501(c)(3) nonprofit professional society founded in 2012 that serves 12,500+ hematologic oncology clinicians and researchers across 120+ countries via free membership, a flagship Houston annual meeting, publications, and global satellite programs.
- Company typePrivate
- Founded2012
- HeadquartersThe Woodlands, United States
- Headcount5,001–10,000
- GTM typeB2C
- OfferingServices
What The Society of Hematologic Oncology does
The Society of Hematologic Oncology (SOHO) is a 501(c)(3) nonprofit professional society founded in 2012 and headquartered in The Woodlands, Texas. It is the only global society specifically dedicated to clinicians, research scientists, and allied health professionals working in hematologic malignancies — leukemias, lymphomas, multiple myeloma, MDS, and MPNs. The society offers free membership to qualified professionals and has grown to 12,504 members across more than 120 countries.
SOHO's core product is the 3.5-day hybrid Annual Meeting held each September at the George R. Brown Convention Center in Houston, expected to draw more than 3,000 attendees in 2026. Supporting products and programs include the SOHO365 mobile app (member engagement and event navigation), the SOHO Insider digital and print news publication (launched January 2025), the one-day virtual SOHO Breakthroughs in Blood Cancers meeting, the SOHO SPOTLIGHT educational podcast, the Clinical Lymphoma, Myeloma & Leukemia (CLML) journal published through Elsevier, and the SOHO Forums online community. The Young Investigator Program and a 121-person international Ambassador Program round out the ecosystem.
The society operates a freemium-plus-events business model: membership is free, with revenue generated from annual meeting registration fees (with 40% member discounts), tiered exhibit and sponsorship packages (Platinum through Bronze) across 90,000+ square feet of exhibit space, journal subscription income, and ancillary services such as negotiated hotel room blocks. SOHO does not develop proprietary technology; its digital platforms are built on standard SaaS infrastructure (iMIS, Clowder, PassKey, OpenEdge, Zoom Webinar).
The Society of Hematologic Oncology firmographics
Firmographics- Name
- The Society of Hematologic Oncology
- Legal name
- Society of Hematologic Oncology
- Website
- https://sohoonline.org
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- SOHO is a 501(c)(3) nonprofit professional society founded in 2012 that serves 12,500+ hematologic oncology clinicians and researchers across 120+ countries via free membership, a flagship Houston annual meeting, publications, and global satellite programs.
- Ownership category
- akta.pro rank
The Society of Hematologic Oncology industry classification
Industry- Product category
- Medical Professional Society (Hematologic Oncology)
- SIC
- Services-Membership Organizations (8600), Services-Health Services (8000)
- akta.pro primary industry
- Hematologic Oncology (Leukemia/Lymphoma/Myeloma) (HLAKAFAD)
- akta.pro secondary industry
- Oncology & Hematology Pharmaceuticals (HLAIAAAC)
Keywords
Where The Society of Hematologic Oncology is headquartered
LocationHeadquarters
- HQ city
- The Woodlands
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
The Society of Hematologic Oncology business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Operations, Personnel, Marketing or Sales, Technology or R&D, Others
Revenue model
- Membership Dues: SOHO offers free membership to qualified physicians, researchers, and healthcare professionals. All membership tiers are free of charge, meaning membership dues do not generate direct revenue. Membership serves as the primary customer acquisition mechanism for other revenue streams.
- Annual Meeting Registration: The annual SOHO meeting generates revenue through registration fees. SOHO members receive a 40% discount on meeting registration. Registration fees vary by category (physician, industry, exhibitor) and deadline period (early, regular, late). The 2026 meeting offers hybrid participation with in-person and virtual options.
- Journal Publication: SOHO has a partnership with Elsevier to publish the official journal 'Clinical Lymphoma, Myeloma & Leukemia' (CLML). International members receive discounted print subscriptions at $145.00 (regular rate $256.00). This represents a recurring revenue stream from publication subscriptions.
- Exhibits and Sponsorships: The annual meeting generates revenue through exhibit booth sales and sponsorship packages at various tiers (Platinum, Gold, Silver, Bronze). The 2026 meeting offers over 90,000 square feet of exhibit space at the George R. Brown Convention Center. Industry supporters pay for exhibit space, sponsorships, and branding opportunities.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Annual | Free membership for all qualified professionals |
| Subscription | Multi-year contract | SOHO 2026 Annual Meeting - Early Bird Registration |
| Subscription | Multi-year contract | SOHO 2026 Annual Meeting - Regular Rates |
| Subscription | Annual | SOHO 2025 Annual Meeting - Early Bird Rates |
| Subscription | Annual | SOHO 2025 Annual Meeting - Regular and Late Rates |
| Subscription | Pay-as-you-go | SOHO Breakthroughs in Blood Cancers Virtual Meeting |
| Subscription | Annual | Clinical Lymphoma, Myeloma & Leukemia Journal (International) |
| Unit Pricing | Pay-as-you-go | Hotel Accommodation - Hilton Americas-Houston |
Go-to-market motion3 records
Distribution channels7 records
Marketing channels15 records
The Society of Hematologic Oncology product offering
Product offeringCore offering
The Society of Hematologic Oncology is a global 501(c)(3) nonprofit professional society that provides continuing medical education, research dissemination, and professional networking for clinicians and scientists treating hematologic malignancies. Its core offerings include a free membership program, a flagship annual hybrid conference in Houston, a peer-reviewed journal (Clinical Lymphoma Myeloma and Leukemia), a member mobile app, virtual and regional satellite meetings, and a moderated online community forum.
Product overview
The Society of Hematologic Oncology operates a platform-plus-programs model centered on education and knowledge exchange for hematologic oncology professionals. The core product is the Annual Meeting, a 3.5-day hybrid conference held in Houston each September covering all hematologic malignancies. Supporting this are the SOHO Insider news publication (launched January 2025), the SOHO365 mobile app for member engagement and meeting participation, the SOHO Breakthroughs in Blood Cancers virtual meeting series, and the SOHO SPOTLIGHT educational podcast. SOHO also publishes the Clinical Lymphoma, Myeloma & Leukemia (CLML) journal through Elsevier partnership, maintains the SOHO Forums community platform, and runs the Ambassador Program (121 international ambassadors) and Young Investigator Program for professional development. Membership is free, and members receive a 40% discount on all meeting registrations.
Differentiator
Problem solved
Functional benefit
Brands
- SOHO Insider: Official news publication of the Society of Hematologic Oncology, providing daily news updates, case studies, video interviews, roundtable discussions, and conference coverage for clinicians, researchers, and industry professionals.
- SOHO365
Products and services
- SOHO Annual Meeting Flagship 3.5-day hybrid conference held each September in Houston, Texas, featuring general sessions, meet-the-professor sessions, plenary lectures, expert sessions, oral abstract presentations, and poster walks covering the latest advances in leukemias, lymphomas, myeloma, MDS, and MPNs. SOHO members receive a 40% registration discount.
- SOHO Insider Official digital and print news publication of SOHO providing daily news updates, case studies, video interviews, roundtable discussions, and conference coverage for clinicians, researchers, and industry professionals. Free online to the public; U.S. members receive free print copies.
- SOHO365 Mobile App Mobile application available on iOS and Android that keeps SOHO members and meeting attendees connected year-round, providing access to member-only resources, interactive forums including 'Ask the Expert' discussions, event agendas, session scheduling, speaker information, and virtual hub navigation for hybrid meetings.
- SOHO SPOTLIGHT Podcast Educational podcast series focused on practical tips and strategies for managing hematologic malignancies including leukemias, lymphomas, multiple myeloma, and myeloproliferative neoplasms, featuring real-world perspectives from leading experts in the field.
- SOHO Breakthroughs in Blood Cancers (SBBC) One-day virtual meeting reviewing current treatments for patients with hematologic malignancies as presented by top global experts, with discussion of near-term future developments in research. Delivered via Zoom Webinar with interactive Q&A. Free for SOHO members; $50 for non-members.
- Clinical Lymphoma, Myeloma & Leukemia (CLML) Journal Official peer-reviewed monthly journal of SOHO, published by Elsevier, featuring original articles describing clinical and translational research of hematologic malignancies including detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia, MDS, and MPNs. Free online access for SOHO members; international members receive discounted print subscription at $145/year versus $256 regular rate.
- SOHO Forums Secure online community platform (soho.clowder.com) for SOHO members to have open, in-depth discussions about clinical questions, cases, and best practices, including expert 'Ask the Expert' forums. Accessed via web and the SOHO365 mobile app.
Quantifiable outcome
- 12,504 members globally (as stated on homepage)
- +2 more outcomes
Companies that use The Society of Hematologic Oncology
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles2 records
The Society of Hematologic Oncology technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
The Society of Hematologic Oncology partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and major.
- ElseviercoreElsevier is the publisher of Clinical Lymphoma, Myeloma & Leukemia (CLML), the official journal of SOHO. The partnership provides members free online access to peer-reviewed clinical and translational research articles on hematologic malignancies. International members receive discounted print subscriptions at $145/year versus $256 regular rate. The journal publishes monthly and includes original articles, reviews, and research specific to lymphoma, myeloma, leukemia, and related disorders.
- George R. Brown Convention CentercorePrimary venue partner for the SOHO Annual Meeting. The convention center in downtown Houston hosts the 3.5-day annual event each September, offering more than 90,000 square feet of exhibit space. Located near Discovery Green, restaurants, and Theater District with skybridge access to the Hilton Americas-Houston hotel.
- Hilton Americas-HoustonmajorOfficial hotel partner with contracted room blocks at negotiated rates for SOHO meeting attendees. Located adjacent to George R. Brown Convention Center with convenient skybridge access. AAA Four Diamond rated hotel with 1,207 guestrooms and 91,500 square feet of meeting space. Preferred SOHO rates of $219-$227 per night plus taxes and fees.
Scale indicators12 records
Recent moves8 records
Expansion highlights4 records
The Society of Hematologic Oncology competitors and assessment
Company assessmentEmerging players
- Lymphoma Research Foundation (LRF): LRF funds lymphoma research and provides professional education including CME and scientific conferences on lymphoma. As a lymphoma-focused organization, it overlaps meaningfully with SOHO's hematologic malignancy remit for sponsors and attendees.
- Leukemia & Lymphoma Society (LLS): LLS is a major US patient-focused nonprofit funding blood cancer research, education, and advocacy. It runs CME programs and professional education that overlap with SOHO's hematologic oncology content, and competes for disease-area sponsorship dollars.
- International Myeloma Foundation (IMF): IMF is a myeloma-focused foundation running the International Myeloma Working Group, annual workshops, and CME. It is a narrower competitor than SOHO but a strong draw for myeloma clinicians and sponsors in SOHO's remit.
- CLL Society: CLL Society is a disease-specific organization focused on chronic lymphocytic leukemia education, research, and patient advocacy. While patient-led, it offers professional symposia and competes for CLL-related sponsor attention that overlaps with SOHO's hematologic malignancy scope.
- Multiple Myeloma Research Foundation (MMRF): MMRF is a leading myeloma-focused research and education nonprofit hosting professional meetings and CME programs. It directly intersects SOHO's myeloma content and competes for myeloma therapy sponsors and clinician attendees.
Direct peers
- International Society of Hematology (ISH): ISH is a global professional society for hematology professionals with biennial world congresses and educational programs. It shares SOHO's international, hematology-only positioning and competes for global hematology clinician mindshare.
- European Hematology Association (EHA): EHA is the European counterpart focused on hematology, running the annual EHA Congress and publishing HemaSphere. It directly mirrors SOHO's hematology-specialty model and competes for international attendees and European pharma sponsors.
Broad incumbents
- American Society of Hematology (ASH): ASH is the largest US professional society for hematology, hosting the annual ASH Annual Meeting & Exposition and publishing Blood, the field's top journal. It is the dominant incumbent SOHO competes with for hematology-focused clinicians, sponsors, and meeting share.
- American Society of Clinical Oncology (ASCO): ASCO is the leading clinical oncology society, with broad oncology membership, the ASCO Annual Meeting, and the Journal of Clinical Oncology. While not hematology-only, it overlaps significantly with SOHO on hematologic malignancy content and sponsor audiences.
- American Association for Cancer Research (AACR): AACR is the largest cancer research society with a broad annual meeting and a portfolio of high-impact journals including Blood Cancer Discovery. It overlaps with SOHO on hematologic malignancy research content and competes for translational research sponsorships.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
The Society of Hematologic Oncology social profiles
Digital presenceThe Society of Hematologic Oncology financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Society of Hematologic Oncology leadership team
Management profileNumber of profiles
Profiles4 records
The Society of Hematologic Oncology subsidiaries and ownership
Company hierarchySubsidiaries8 records
The Society of Hematologic Oncology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Society of Hematologic Oncology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Society of Hematologic Oncology
What does The Society of Hematologic Oncology do?
The Society of Hematologic Oncology is a global 501(c)(3) nonprofit professional society that provides continuing medical education, research dissemination, and professional networking for clinicians and scientists treating hematologic malignancies. Its core offerings include a free membership program, a flagship annual hybrid conference in Houston, a peer-reviewed journal (Clinical Lymphoma Myeloma and Leukemia), a member mobile app, virtual and regional satellite meetings, and a moderated online community forum.
Is The Society of Hematologic Oncology a public or private company?
The Society of Hematologic Oncology is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was The Society of Hematologic Oncology founded?
The Society of Hematologic Oncology was founded in 2012. It employs 5,001 to 10,000 people.
Where is The Society of Hematologic Oncology based?
The Society of Hematologic Oncology is headquartered in The Woodlands, United States, in the North America region.
How does The Society of Hematologic Oncology make money?
Four revenue lines are on record. Membership Dues are the primary driver. The others are annual Meeting Registration, journal Publication and exhibits and Sponsorships.
Who are The Society of Hematologic Oncology's main competitors?
Emerging players on record are Lymphoma Research Foundation (LRF), Leukemia & Lymphoma Society (LLS), International Myeloma Foundation (IMF), CLL Society and Multiple Myeloma Research Foundation (MMRF). Direct peers are International Society of Hematology (ISH) and European Hematology Association (EHA). Broad incumbents are American Society of Hematology (ASH), American Society of Clinical Oncology (ASCO) and American Association for Cancer Research (AACR).
Does The Society of Hematologic Oncology have an API?
No public API is recorded for The Society of Hematologic Oncology.
What industry is The Society of Hematologic Oncology in?
The Society of Hematologic Oncology's product category is Medical Professional Society (Hematologic Oncology). Its primary akta.pro industry code is HLAKAFAD, Hematologic Oncology (Leukemia/Lymphoma/Myeloma), with a secondary code of HLAIAAAC, Oncology & Hematology Pharmaceuticals. Its SIC code is 8600.